Stockscreener 앱 받기
1.42
0.00%
0.00
시간 외 거래:
1.44
0.02
+1.41%
전일 마감가:
$1.42
열려 있는:
$1.44
하루 거래량:
1.23M
Relative Volume:
0.80
시가총액:
$454.58M
수익:
$6.23M
순이익/손실:
$-95.90M
주가수익비율:
-3.641
EPS:
-0.39
순현금흐름:
$-68.47M
1주 성능:
-4.05%
1개월 성능:
+7.58%
6개월 성능:
+52.18%
1년 성능:
-10.13%
1일 변동 폭
$1.40
$1.45
1주일 범위
$1.39
$1.55
52주 변동 폭
$0.6513
$2.17
Precigen Inc Stock (PGEN) Company Profile
명칭
Precigen Inc
전화
301-556-9900
주소
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
PGEN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PGEN
Precigen Inc
|
1.42 | 454.58M | 6.23M | -95.90M | -68.47M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
445.20 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
525.00 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
326.09 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
551.22 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
242.07 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-03-22 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-05-23 | 개시 | JP Morgan | Neutral |
| 2022-11-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-02-25 | 개시 | Stifel | Buy |
| 2021-02-22 | 개시 | Wells Fargo | Overweight |
| 2021-02-18 | 개시 | B. Riley Securities | Buy |
| 2020-05-08 | 개시 | H.C. Wainwright | Buy |
모두보기
Precigen Inc 주식(PGEN)의 최신 뉴스
Closing Strong: Precigen Inc (PGEN) Ends at 1.42, Down -7.79 from Last Close - DWinneX
High Growth Tech Stocks To Watch In The US June 2025 - simplywall.st
Bank of America Corp DE Has $232,000 Position in Precigen, Inc. (NASDAQ:PGEN) - Defense World
Precigen stock price target maintained at $6 by JMP on RRP therapy - Investing.com Nigeria
Precigen’s SWOT analysis: gene therapy firm’s stock poised for potential breakthrough - Investing.com Australia
Precigen (NASDAQ:PGEN) Given “Market Outperform” Rating at JMP Securities - Defense World
JMP Securities Reiterates PGEN with Market Outperform Rating | P - GuruFocus
JMP Securities Reiterates PGEN with Market Outperform Rating | PGEN Stock News - GuruFocus
Precigen, Inc.'s (NASDAQ:PGEN) market cap touched US$455m last week, benefiting both private equity firms who own 33% as well as institutions - Yahoo Finance
Cantor Fitzgerald Weighs in on Precigen FY2026 Earnings - Defense World
BNP Paribas Financial Markets Acquires New Position in Precigen, Inc. (NASDAQ:PGEN) - Defense World
ProShare Advisors LLC Buys 10,900 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World
Top 5 Synthetic Biology Public Companies (June 2025) - Securities.io
Precigen, Inc. (NASDAQ:PGEN) Shares Acquired by Cetera Investment Advisers - Defense World
Precigen, Inc. (NASDAQ:PGEN) Shares Purchased by Northern Trust Corp - Defense World
D. E. Shaw & Co. Inc. Sells 792,731 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World
Precigen (NASDAQ:PGEN) Downgraded to “Sell” Rating by Wall Street Zen - Defense World
Precigen, Inc. Reports Q1 2025 Financial Results - TipRanks
FY2025 EPS Estimates for Precigen Cut by Cantor Fitzgerald - Defense World
HC Wainwright Decreases Earnings Estimates for Precigen - Defense World
FY2027 EPS Estimates for Precigen Reduced by HC Wainwright - Defense World
Precigen, Inc. (NASDAQ:PGEN) Shares Sold by Price T Rowe Associates Inc. MD - Defense World
Cantor Fitzgerald Reiterates “Overweight” Rating for Precigen (NASDAQ:PGEN) - Defense World
Precigen First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Stifel Financial Corp Acquires 58,657 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World
Cantor Fitzgerald maintains Overweight on Precigen stock By Investing.com - Investing.com South Africa
Precigen (PGEN) Rating Reaffirmed as Overweight by Cantor Fitzge - GuruFocus
Precigen (PGEN) Rating Reaffirmed as Overweight by Cantor Fitzgerald | PGEN Stock News - GuruFocus
JMP maintains Precigen stock $6 target on PRGN-2012 optimism By Investing.com - Investing.com Nigeria
JMP maintains Precigen stock $6 target on PRGN-2012 optimism - Investing.com Australia
Cantor Fitzgerald maintains Overweight on Precigen stock - Investing.com
Precigen Reports First Quarter 2025 Financial Results and Business Updates - StreetInsider
Precigen Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Precigen Inc (PGEN) Q1 2025 Earnings: Revenue Surges 26% to $1.4 - GuruFocus
Precigen Reports First Quarter 2025 Financial Results and Busine - GuruFocus
Precigen Reports First Quarter 2025 Financial Results and Business Updates | PGEN Stock News - GuruFocus
Barclays PLC Purchases 53,546 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World
Precigen (PGEN) to Release Earnings on Tuesday - Defense World
Wells Fargo & Company MN Increases Stake in Precigen, Inc. (NASDAQ:PGEN) - Defense World
Precigen : to Announce First Quarter 2020 Financial Results on May 6th - marketscreener.com
Precigen Inc expected to post a loss of 8 cents a shareEarnings Preview - TradingView
LPL Financial LLC Trims Stock Position in Precigen, Inc. (NASDAQ:PGEN) - Defense World
Precision BioSciences Announces Multiple Presentations for In Vivo Gene Editing Programs at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting - Business Wire
There is no way Precigen Inc (PGEN) can keep these numbers up - Sete News
Precigen, Inc. (NASDAQ:PGEN) Shares Sold by Renaissance Technologies LLC - Defense World
Precigen Inc [PGEN] Insider Activity: An Update for Investors - knoxdaily.com
Precigen Inc (PGEN) stock analysis: A comprehensive overview - uspostnews.com
Geode Capital Management LLC Acquires 53,343 Shares of Precigen, Inc. (NASDAQ:PGEN) - Defense World
JPMorgan Chase & Co. Lowers Stock Position in Precigen, Inc. (NASDAQ:PGEN) - Defense World
Intrexon : Precigen Completes Series Of Transactions To Solidify Healthcare Focus - marketscreener.com
Press Release Distribution & PR Platform - ACCESS Newswire
Precigen Inc (PGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Precigen Inc 주식 (PGEN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Perez Jeffrey Thomas | SVP, IP Affairs |
Aug 09 '24 |
Buy |
0.85 |
58,823 |
50,000 |
743,097 |
| KIRK RANDAL J | Director |
Aug 09 '24 |
Buy |
0.85 |
23,529,411 |
19,999,999 |
64,547,214 |
0.78%
0.23%
자본화:
|
볼륨(24시간):